The Charlson comorbidity index in registry-based research
N Brusselaers, J Lagergren - Methods of information in …, 2017 - thieme-connect.com
Background: Comorbidities may have an important impact on survival, and comorbidity
scores are often implemented in studies assessing prognosis. The Charlson Comorbidity …
scores are often implemented in studies assessing prognosis. The Charlson Comorbidity …
[HTML][HTML] Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases
RA Marrie, R Walld, JM Bolton, J Sareen… - General hospital …, 2018 - Elsevier
Objective We determined the association between any common mental disorder (CMD:
depression, anxiety disorder, bipolar disorder) and mortality and suicide in three immune …
depression, anxiety disorder, bipolar disorder) and mortality and suicide in three immune …
Performance of FRAX in women with breast cancer initiating aromatase inhibitor therapy: a registry‐based cohort study
ABSTRACT FRAX was developed to predict 10‐year probability of major osteoporotic
fracture (MOF) and hip fracture in the general population. Aromatase inhibitors (AI) used in …
fracture (MOF) and hip fracture in the general population. Aromatase inhibitors (AI) used in …
[HTML][HTML] Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide …
Background Cancer patients have a highly increased risk of psychiatric disorders following
diagnosis, compared with cancer-free individuals. Inflammation is involved in the …
diagnosis, compared with cancer-free individuals. Inflammation is involved in the …
[HTML][HTML] Comparing chronic condition rates using ICD-9 and ICD-10 in VA patients FY2014–2016
J Yoon, A Chow - BMC health services research, 2017 - Springer
Background Management of patients with chronic conditions relies on accurate
measurement. It is unknown how transition to the ICD-10 coding system affected reporting of …
measurement. It is unknown how transition to the ICD-10 coding system affected reporting of …
A novel risk calculator predicts 90-day readmission following total joint arthroplasty
DE Goltz, SP Ryan, TJ Hopkins, CB Howell… - JBJS, 2019 - journals.lww.com
Background: A reliable prediction tool for 90-day adverse events not only would provide
patients with valuable estimates of their individual risk perioperatively, but would also give …
patients with valuable estimates of their individual risk perioperatively, but would also give …
[HTML][HTML] Incidence and prevalence, and medication use among adults living with dermatomyositis: an Alberta, Canada population-based cohort study
M Osman, KJB Martins, KO Wong, K Vu, A Guigue… - Scientific Reports, 2023 - nature.com
Dermatomyositis is a rare disease characterized by progressive muscle weakness and skin
rashes. Estimates of incidence and prevalence are fundamental measures in epidemiology …
rashes. Estimates of incidence and prevalence are fundamental measures in epidemiology …
Appropriate patient selection for outpatient shoulder arthroplasty: a risk prediction tool
DE Goltz, RA Burnett, JM Levin, JR Wickman… - Journal of shoulder and …, 2022 - Elsevier
Background The transition from inpatient to outpatient shoulder arthroplasty critically
depends on appropriate patient selection, both to ensure safety and to counsel patients …
depends on appropriate patient selection, both to ensure safety and to counsel patients …
Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population‐based cross‐sectional study
AL Mahar, K Biggs, RL Hansford, S Derksen… - Cancer, 2024 - Wiley Online Library
Background Cancer is a leading cause of death among people living with intellectual or
developmental disabilities (IDD). Although studies have documented lower cancer …
developmental disabilities (IDD). Although studies have documented lower cancer …
A weighted index of Elixhauser comorbidities for predicting 90-day readmission after total joint arthroplasty
DE Goltz, SP Ryan, CB Howell, D Attarian… - The Journal of …, 2019 - Elsevier
Background Evolving reimbursement models increasingly compel hospitals to assume costs
for 90-day readmission after total joint arthroplasty. Although risk assessment tools exist …
for 90-day readmission after total joint arthroplasty. Although risk assessment tools exist …